What are the recommended loading and maintenance doses of phenytoin for adults (including elderly) and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Phenytoin Dosing Recommendations

Loading Doses

For status epilepticus in adults, administer phenytoin 18-20 mg/kg IV at a maximum infusion rate of 50 mg/min (maximum total loading dose: 1000-1500 mg). 1, 2

Adults (Status Epilepticus)

  • Loading dose: 18-20 mg/kg IV
  • Infusion rate: Maximum 50 mg/min
  • Maximum dose: 1000-1500 mg total
  • Alternative (fosphenytoin): 18-20 PE/kg IV at maximum rate of 150 PE/min 1, 2

Pediatric Patients (Status Epilepticus)

  • Children: 20 mg/kg IV (maximum initial dose: 1000 mg) 1
  • Neonates: 10 mg/kg IV 1
  • Infusion rate: Not to exceed 1 mg/kg/min 1
  • Infusion time: 10-20 minutes recommended 1

Critical caveat: Neonates have increased toxicity risk due to decreased protein binding; phenobarbital is preferred in this age group 1. Fosphenytoin is preferred over phenytoin when available due to lower cardiac adverse effects 1.

Oral Loading (Non-Emergency)

For adults requiring rapid therapeutic levels where IV administration is not desirable:

  • Initial: 1000 mg divided into three doses (400 mg, 300 mg, 300 mg) given at 2-hour intervals 3
  • Restriction: Reserved for clinic/hospital settings with serum level monitoring capability
  • Contraindication: Do not use in patients with renal or liver disease 3
  • Begin normal maintenance 24 hours after loading dose 3

Maintenance Doses

Adults

Standard maintenance dosing is 4-7 mg/kg/day, typically administered as 300 mg daily in divided doses or once-daily for extended-release formulations. 3, 4

  • Initial: 100 mg three times daily (300 mg/day total) 3
  • Range: 300-400 mg/day for most adults 3
  • Maximum: Up to 600 mg/day (two capsules three times daily) if needed 3
  • Once-daily option: 300 mg extended-release capsules once daily (only for patients already controlled on this total daily dose) 3

Important: Only extended phenytoin sodium capsules (Dilantin) are appropriate for once-daily dosing due to dissolution characteristics 3. Other formulations require divided dosing.

Pediatric Patients

  • Initial: 5 mg/kg/day divided into 2-3 equal doses 3
  • Maintenance range: 4-8 mg/kg/day 3
  • Maximum: 300 mg/day 3
  • Children >6 years and adolescents: May require minimum adult dose (300 mg/day) 3

Elderly Patients

Use the same weight-based dosing as adults, but recognize that elderly patients may require lower doses due to altered pharmacokinetics. Start at the lower end of the dosing range and titrate carefully with serum level monitoring.


Critical Monitoring and Safety Considerations

Therapeutic Drug Monitoring

  • Target serum level: 10-20 mcg/mL 1, 3
  • Time to steady state: 7-10 days 3
  • Dosage adjustment interval: Do not adjust more frequently than every 7-10 days 3
  • Post-loading level timing: Measure 2 hours after IV loading completion 5, 6

Administration Precautions

Phenytoin IV:

  • Dilute in normal saline only (incompatible with glucose-containing solutions) 1
  • Requires filter and infusion pump 2
  • Monitor heart rate continuously; reduce infusion rate if heart rate decreases by 10 beats/min 1
  • Risk of hypotension, bradyarrhythmias, cardiac arrest, and extravasation injuries 2

Fosphenytoin IV:

  • Can be given IM if needed 2
  • Lower risk of hypotension and cardiac effects compared to phenytoin 1, 2
  • Fewer adverse events in head-to-head comparisons 2
  • Itching is common but controllable by reducing flow rate 1

Common Pitfalls to Avoid

  1. Weight estimation errors: Using estimated weights in children can result in 78-138% of intended dose 6. Use actual weights whenever possible.

  2. Formulation switching: Inherent differences in dissolution characteristics between manufacturers and formulations require close serum level monitoring when switching products 3.

  3. Free acid vs. sodium salt: Approximately 8% increase in drug content with free acid form; dosage adjustments may be necessary when switching 3.

  4. Premature dose adjustments: Waiting less than 7-10 days between dose changes prevents achievement of steady state 3.

  5. Respiratory support: Increased incidence of apnea when combined with benzodiazepines or other sedatives—be prepared to provide respiratory support 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.